AΒ mediated diminution of MTT reduction - An artefact of single cell culture?

PLoS ONE

Volumn 3, Issue 9, 2008, Pages

  Rönicke, Raik ^a   Klemm, Anja ^a   Meinhardt, Jessica ^c   Schröder, Ulrich H ^a   Fändrich, Marcus ^d,e   Reymann, Klaus G ^a,b  

^a LEIBNIZ INSTITUTE FOR NEUROBIOLOGY   (Germany)

^b Res Inst of Appl Neurosci gGmbH   (Germany)

^c FRITZ LIPMANN INSTITUTE   (Germany)

^d MAX PLANCK RESEARCH UNIT FOR ENZYMOLOGY OF PROTEIN FOLDING   (Germany)

^e MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN[25-35]; OLIGOMER; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL ASSAY; CELL VIABILITY; CONTROLLED STUDY; DRUG RESEARCH; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; LONG TERM POTENTIATION; MACROGLIA; MALE; NERVE CELL CULTURE; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NONHUMAN; PROTEIN AGGREGATION; RAT; RELIABILITY; REPRODUCIBILITY; SYNAPTIC TRANSMISSION; ALZHEIMER DISEASE; ANIMAL; ASTROCYTE; BRAIN; CHEMISTRY; DRUG EFFECT; ELECTROPHYSIOLOGY; METABOLISM; MICROGLIA; NERVE CELL; PRENATAL DEVELOPMENT; SYNAPSE; WISTAR RAT;

RATTUS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ASTROCYTES; BRAIN; ELECTROPHYSIOLOGY; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; MICROGLIA; NEURONS; RATS; RATS, WISTAR; SYNAPSES; TETRAZOLIUM SALTS; THIAZOLES;

EID: 52449104067     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003236     Document Type: Article

References (62)

1. Walsh DM, Selkoe DJ (2007) A beta oligomers - a decade of discovery. J Neurochem 101: 1172-1184.
2. Liu Y (1999) Understanding the biological activity of amyloid proteins in vitro: from inhibited cellular MTT reduction to altered cellular cholesterol homeostatis. Prog Neuropsychopharmacol Biol Psychiatry 23: 377-395.
3. Hayon T, Dvilansky A, Shpilberg O, Nathan I (2003) Appraisal of the MTT-based assay as a useful tool for predicting drug chemosensitivity in leukemia. Leuk Lymphoma 44: 1957-1962.
4. Latini A, da Silva CG, Ferreira GC, Schuck PF, Scussiato K, et al. (2005) Mitochondrial energy metabolism is markedly impaired by D-2-hydroxyglutaric acid in rat tissues. Mol Genet Metab 86: 188-199.
5. Lushnikova IV, Voronin KY, Malyarevskyy PY, Skibo GG (2004) Morphological and functional changes in rat hippocampal slice cultures after short-term oxygen-glucose deprivation. J Cell Mol Med 8: 241-248.
6. Liu ML, Hong ST (2005) Early phase of amyloid beta42-induced cytotoxicity in neuronal cells is associated with vacuole formation and enhancement of exocytosis. Exp Mol Med 37: 559-566.
7. Shearman MS, Ragan CI, Iversen LL (1994) Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death. Proc Natl Acad Sci U S A 91: 1470-1474.
8. Kaneko I, Yamada N, Sakuraba Y, Kamenosono M, Tutumi S (1995) Suppression of mitochondrial succinate dehydrogenase, a primary target of beta-amyloid, and its derivative racemized at Ser residue. J Neurochem 65: 2585-2593.
9. Liu Y, Schubert D (1997) Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis. J Neurochem 69: 2285-2293.
10. Abe K, Saito H (1998) Amyloid beta protein inhibits cellular MTT reduction not by suppression of mitochondrial succinate dehydrogenase but by acceleration of MTT formazan exocytosis in cultured rat cortical astrocytes. Neurosci Res 31: 295-305.
11. Bieschke J, Siegel SJ, Fu Y, Kelly JW (2008) Alzheimer's Abeta Peptides Containing an Isostructural Backbone Mutation Afford Distinct Aggregate Morphologies but Analogous Cytotoxicity. Evidence for a Common Low-Abundance Toxic Structure(s)? Biochemistry 47: 50-59.
12. Boutaud O, Montine TJ, Chang L, Klein WL, Oates JA (2006) PGH2-derived levuglandin adducts increase the neurotoxicity of amyloid beta1-42. J Neurochem 96: 917-923.
13. Choi SJ, Kim MJ, Heo HJ, Kim HK, Hong B, et al. (2006) Protective effect of Rosa laevigata against amyloid beta peptide-induced oxidative stress. Amyloid 13: 6-12.
14. Szegedi V, Juhasz G, Rozsa E, Juhasz-Vedres G, Datki Z, et al. (2006) Endomorphin-2, an endogenous tetrapeptide, protects against Abeta1-42 in vitro and in vivo. FASEB J 20: 1191-1193.
15. Sundstrom L, Morrison B, Bradley M, Pringle A (2005) Organotypic cultures as tools for functional screening in the CNS. Drug Discov Today 10: 993-1000.
16. Neumann J, Gunzer M, Gutzeit HO, Ullrich O, Reymann KG, et al. (2006) Microglia provide neuroprotection after ischemia. FASEB J 20: 714-716.
17. Noraberg J, Poulsen FR, Blaabjerg M, Kristensen BW, Bonde C, et al. (2005) Organotypic hippocampal slice cultures for studies of brain damage, neuroprotection and neurorepair. Curr Drug Targets CNS Neurol Disord 4: 435-452.
18. Imai T, Kosuge Y, Ishige K, Ito Y (2007) Amyloid beta-protein potentiates tunicamycin-induced neuronal death in organotypic hippocampal slice cultures. Neuroscience 147: 639-651.
19. Wang X, Takata T, Sakurai T, Yokono K (2007) Different effects of monocarboxylates on neuronal survival and beta-amyloid toxicity. Eur J Neurosci 26: 2142-2150.
20. Xu K, Malouf AT, Messing A, Silver J (1999) Glial fibrillary acidic protein is necessary for mature astrocytes to react to beta-amyloid. Glia 25: 390-403.
21. Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, et al. (2007) Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 27: 2866-2875.
22. Connelly CA, Chen LC, Colquhoun SD (2000) Metabolic activity of cultured rat brainstem, hippocampal and spinal cord slices. J Neurosci Methods 99: 1-7.
23. Holscher C, Gengler S, Gault VA, Harriott P, Mallot HA (2007) Soluble beta-amyloid [25-35] reversibly impairs hippocampal synaptic plasticity and spatial learning. Eur J Pharmacol 561: 85-90.
24. Kato M, Saito H, Abe K (1997) Nanomolar amyloid beta protein-induced inhibition of cellular redox activity in cultured astrocytes. J Neurochem 68: 1889-1895.
25. Fandrich M (2007) On the structural definition of amyloid fibrils and other polypeptide aggregates. Cell Mol Life Sci 64: 2066-2078.
26. Barghorn S, Nimmrich V, Striebinger A, Krantz C, Keller P, et al. (2005) Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. J Neurochem 95: 834-847.
27. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, et al. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300: 486-489.
28. Rowan MJ, Klyubin I, Wang Q, Hu NW, Anwyl R (2007) Synaptic memory mechanisms: Alzheimer's disease amyloid beta-peptide-induced dysfunction. Biochem Soc Trans 35: 1219-1223.
29. Reymann KG, Frey JU (2007) The late maintenance of hippocampal LTP: requirements, phases, 'synaptic tagging', 'late-associativity' and implications. Neuropharmacology 52: 24-40.
30. Abe K, Kato M, Saito H (1997) Congo red reverses amyloid beta protein-induced cellular stress in astrocytes. Neurosci Res 29: 129-134.
31. Kimura T, Hauber J, Singer TP (1967) Studies on succinate dehydrogenase. 13. Reversible activation of the mammalian enzyme. J Biol Chem 242: 4987-4993.
32. Gil A, Viniegra S, Gutierrez LM (2001) Temperature and PMA affect different phases of exocytosis in bovine chromaffin cells. Eur J Neurosci 13: 1380-1386.
33. Kachadorian WA, Muller J, Finkelstein A (1981) Role of osmotic forces in exocytosis: studies of ADH-induced fusion in toad urinary bladder. J Cell Biol 91: 584-588.
34. Johansson S, Radesater AC, Cowburn RF, Thyberg J, Luthman J (2006) Modelling of amyloid beta-peptide induced lesions using roller-drum incubation of hippocampal slice cultures from neonatal rats. Exp Brain Res 168: 11-24.
35. Ioudina M, Uemura E (2003) A three amino acid peptide, Gly-Pro-Arg, protects and rescues cell death induced by amyloid beta-peptide. Exp Neurol 184: 923-929.
36. Korotzer AR, Whittemore ER, Cotman CW (1995) Differential regulation by beta-amyloid peptides of intracellular free Ca2+ concentration in cultured rat microglia. Eur J Pharmacol 288: 125-130.
37. Baskys A, Adamchik Y (2001) Neuroprotective effects of extracellular glutamate are absent in hippocampal organotypic cultures treated with the amyloid peptide Abeta(25-35). Brain Res 907: 188-194.
38. Ito Y, Ito M, Takagi N, Saito H, Ishige K (2003) Neurotoxicity induced by amyloid beta-peptide and ibotenic acid in organotypic hippocampal cultures: protection by S-allyl-L-cysteine, a garlic compound. Brain Res 19985: 98-107.
39. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, et al. (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 95: 6448-6453.
40. Chong YH, Shin YJ, Lee EO, Kayed R, Glabe CG, et al. (2006) ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures. J Biol Chem 281: 20315-20325.
41. Yankner BA, Duffy LK, Kirschner DA (1990) Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250: 279-282.
42. Lane RM, Farlow MR (2005) Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease. J Lipid Res 46: 949-968.
43. Williamson R, Usardi A, Hanger DP, Anderton BH (2007) Membrane-bound {beta}-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism. FASEB J.
44. Ishige K, Takagi N, Imai T, Rausch WD, Kosuge Y, et al. (2007) Role of caspase-12 in amyloid beta-peptide-induced toxicity in organotypic hippocampal slices cultured for long periods. J Pharmacol Sci 104: 46-55.
45. Podlisny MB, Stephenson DT, Frosch MP, Tolan DR, Lieberburg I, et al. (1993) Microinjection of synthetic amyloid beta-protein in monkey cerebral cortex fails to produce acute neurotoxicity. Am J Pathol 142: 17-24.
46. Geula C, Wu CK, Saroff D, Lorenzo A, Yuan M, et al. (1998) Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity. Nat Med 4(7): 827-31.
47. Walsh DM, Klyubin I, Fadeeva JV, Rowan MJ, Selkoe DJ (2002) Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition. Biochem Soc Trans 30: 552-557.
48. Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, et al. (2005) Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 8: 79-84.
49. Glabe CG (2006) Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol Aging 27: 570-575.
50. Viola KL, Velasco PT, Klein WL (2008) Why Alzheimer's Is a Disease of Memory: The Attack on Synapses by A beta Oligomers (ADDLs). J Nutr Health Aging 12: 51S-57S.
51. Walsh DM, Klyubin I, Shankar GM, Townsend M, Fadeeva JV, et al. (2005) The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention. Biochem Soc Trans 33: 1087-1090.
52. Walsh DM, Hartley DM, Kusumoto Y, Fezoui Y, Condron MM, et al. (1999) Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J Biol Chem 274: 25945-25952.
53. Wogulis M, Wright S, Cunningham D, Chilcote T, Powell K, et al. (2005) Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death. J Neurosci 25: 1071-1080.
54. Lee CC, Kuo YM, Huang CC, Hsu KS (2007) Insulin rescues amyloid beta-induced impairment of hippocampal long-term potentiation. Neurobiol Aging.
55. Gengler S, Gault VA, Harriott P, Holscher C (2007) Impairments of hippocampal synaptic plasticity induced by aggregated beta-amyloid (25-35) are dependent on stimulation-protocol and genetic background. Exp Brain Res 179: 621-630.
56. Braun H, Buhnemann C, Neumann J, Reymann KG (2006) Preparation of a tissue-like cortical primary culture from embryonic rats using Matrigel and serum free Start V Medium. J Neurosci Methods 157: 32-38.
57. Christopeit T, Hortschansky P, Schroeckh V, Guhrs K, Zandomeneghi G, et al. (2005) Mutagenic analysis of the nucleation propensity of oxidized Alzheimer's beta-amyloid peptide. Protein Sci 14: 2125-2131.
58. Breder J, Sabelhaus CF, Opitz T, Reymann KG, Schroder UH (2000) Inhibition of different pathways influencing Na(+) homeostasis protects organotypic hippocampal slice cultures from hypoxic/hypoglycemic injury. Neuropharmacology 39: 1779-1787.
59. Habicht G, Haupt C, Friedrich RP, Hortschansky P, Sachse C, et al. (2007) Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Abeta protofibrils. Proc Natl Acad Sci U S A 104: 19232-19237.
60. Schroder UH, Hock FJ, Wirth K, Englert HC, Reymann KG (2004) The ATP-regulated K+-channel inhibitor HMR-1372 affects synaptic plasticity in hippocampal slices. Eur J Pharmacol 502: 99-104.
61. Baldauf K, Reymann KG (2005) Influence of EGF/bFGF treatment on proliferation, early neurogenesis and infarct volume after transient focal ischemia. Brain Res 1056: 158-167.
62. Paxinos G, Watson C (1998) The Rat Brain in Stereotaxic Coordinates (fourth ed.). New York: Academic Press.